GILDER GAGNON HOWE & CO LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 169 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$0
-100.0%
290.0%0.00%
Q3 2021$1,0000.0%290.0%0.00%
Q2 2021$1,0000.0%290.0%0.00%
Q1 2021$1,0000.0%29
-29.3%
0.00%
Q4 2020$1,000
-100.0%
41
-99.9%
0.00%
-100.0%
Q3 2020$2,331,000
-66.1%
61,816
-61.5%
0.01%
-74.1%
Q2 2020$6,873,000
+11957.9%
160,520
+7256.6%
0.05%
+5300.0%
Q4 2019$57,000
-3.4%
2,1820.0%0.00%0.0%
Q3 2019$59,0000.0%2,1820.0%0.00%0.0%
Q2 2019$59,000
-6.3%
2,1820.0%0.00%0.0%
Q1 2019$63,000
+5.0%
2,182
-1.8%
0.00%0.0%
Q4 2018$60,0002,2230.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$26,829,00010.04%
Wildcat Capital Management, LLC 1,716,370$25,608,0004.17%
TPG GP A, LLC 18,716,306$279,247,0002.79%
Casdin Capital, LLC 2,650,000$39,538,0001.11%
Lombard Odier Asset Management (Switzerland) SA 996,116$14,862,0000.95%
Coastal Bridge Advisors, LLC 301,929$4,505,0000.94%
HARBOR CAPITAL ADVISORS, INC. 119,547$1,784,0000.65%
Pier Capital, LLC 294,968$4,401,0000.46%
Navalign, LLC 64,428$961,0000.38%
Gratus Capital, LLC 191,871$2,863,0000.26%
View complete list of ALLOGENE THERAPEUTICS INC shareholders